TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT: Erratum

Qing Liu^1,2#, Shutao Zheng^1,2#, Yumei Chen², Tao Liu³, Xiujuan Han², Xiao Zhang², Tongxue Shen², Xiaomei Lu^1,2

1. Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR China.
2. State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian, Xinjiang Uygur Autonomous Region, Urumqi, PR China.
3. Health Management Center, Xinjiang Medical University, Xinjiang Uygur Autonomous Region, Urumqi, PR China.
#Co-first authors.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

Citation:
Liu Q, Zheng S, Chen Y, Liu T, Han X, Zhang X, Shen T, Lu X. TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT: Erratum. J Cancer 2022; 13(8):2414. doi:10.7150/jca.73596. Available from https://www.jcancer.org/v13p2414.htm

Corrected-article in J Cancer, Volume 11, 6892

In our paper [1], we come to realize that Figure 4D was mistakenly taken for Figure 3C that was the same as Figure 4D when preparing the manuscript. The corrected Figure 4D was provided below. The correction made in this erratum will not affect the results and conclusions we drew. We apologize for this error and for any inconvenience that may bring about to the readers and the editors of the journal.

Figure 4

(D) The migratory variations of ESCC cells were analyzed using a wound healing assay after treatment with TGF-β1 inhibitor. Magnification: 100× (*, P<0.05).

(View in new window)

References

1. Liu Q, Zheng S, Chen Y, Liu T, Han X, Zhang X, Shen T, Lu X. TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT. J Cancer. 2020;11(23):6892-6901 doi:10.7150/jca.48426

Author contact

Corresponding author: Dr Xiaomei Lu; Clinical Medical Research Institute, First Affiliated Hospital of Xinjiang Medical University; State Key Laboratory of Pathogenesis, Prevention, Treatment of High Incidence Diseases in Central Asian, Urumqi 830054, Xinjiang Uygur Autonomous Region, PR China. E-mail: luxiaomei88com.

Published 2022-4-25